triethylenemelamine has been researched along with Idiopathic Parkinson Disease in 1 studies
Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olanow, CW | 1 |
| Kieburtz, K | 1 |
| Leinonen, M | 1 |
| Elmer, L | 1 |
| Giladi, N | 1 |
| Hauser, RA | 1 |
| Klepiskaya, OS | 1 |
| Kreitzman, DL | 1 |
| Lew, MF | 1 |
| Russell, DS | 1 |
| Kadosh, S | 1 |
| Litman, P | 1 |
| Friedman, H | 1 |
| Linvah, N | 1 |
| The P B Study Group, F | 1 |
1 trial available for triethylenemelamine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
A randomized trial of a low-dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Delayed-Action Preparations; Double-Blind Method; Drug C | 2017 |